Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
2 studies found for:    CDP323
Show Display Options
Rank Status Study
1 Terminated Placebo Controlled Study in Subjects With Relapsing Forms of MS to Evaluate the Safety, Tolerability and Effects of CDP323
Condition: Multiple Sclerosis
Interventions: Drug: CDP323;   Drug: placebo
2 Completed CDP323 Biomarker Study
Condition: Relapsing Multiple Sclerosis
Interventions: Drug: CDP323;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.